A consensus statement on the use of ketamine in the treatment of mood disorders

for the American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments

Research output: Contribution to journalReview article

169 Scopus citations

Fingerprint Dive into the research topics of 'A consensus statement on the use of ketamine in the treatment of mood disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences